The store will not work correctly when cookies are disabled.
5-(4-(2-Ethyl-3-hydroxy-4-oxopyridin-1(4H)-yl)butoxy)-2,5-dioxopentan-1-aminium Chloride
ID: ALA4082543
PubChem CID: 137646485
Max Phase: Preclinical
Molecular Formula: C16H25ClN2O5
Molecular Weight: 324.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCc1c(O)c(=O)ccn1CCCCOC(=O)CCC(=O)CN.Cl
Standard InChI: InChI=1S/C16H24N2O5.ClH/c1-2-13-16(22)14(20)7-9-18(13)8-3-4-10-23-15(21)6-5-12(19)11-17;/h7,9,22H,2-6,8,10-11,17H2,1H3;1H
Standard InChI Key: OREJSYHDKSLJKW-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 23 0 0 0 0 0 0 0 0999 V2000
2.3571 -10.4598 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.9958 -9.5584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7103 -9.1459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2814 -9.1459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9958 -10.3834 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5669 -9.5584 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4248 -9.5584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1392 -9.1459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8537 -9.5584 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1392 -8.3209 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5683 -9.1459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2827 -9.5584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9972 -9.1459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7117 -9.5584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4261 -9.1459 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1359 -9.5593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8482 -9.1504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8526 -8.3249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1382 -7.9103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4196 -8.3209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5685 -7.9152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.1333 -10.3844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4176 -10.7946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5612 -9.5655 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 1 0
2 5 2 0
4 6 1 0
3 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
15 20 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 2 0
18 21 2 0
16 22 1 0
22 23 1 0
17 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.38 | Molecular Weight (Monoisotopic): 324.1685 | AlogP: 0.75 | #Rotatable Bonds: 10 |
Polar Surface Area: 111.62 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.51 | CX Basic pKa: 7.83 | CX LogP: 0.69 | CX LogD: 0.12 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.49 | Np Likeness Score: -0.16 |
References
1. Battah S, Hider RC, MacRobert AJ, Dobbin PS, Zhou T.. (2017) Hydroxypyridinone and 5-Aminolaevulinic Acid Conjugates for Photodynamic Therapy., 60 (8): [PMID:28363026] [10.1021/acs.jmedchem.7b00346] |